Wells Fargo’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-454
Closed -$104 6680
2024
Q4
$104 Hold
454
﹤0.01% 5907
2024
Q3
$976 Hold
454
﹤0.01% 5717
2024
Q2
$2.34K Sell
454
-163
-26% -$840 ﹤0.01% 5606
2024
Q1
$3.3K Buy
617
+77
+14% +$412 ﹤0.01% 5562
2023
Q4
$4.2K Sell
540
-101
-16% -$786 ﹤0.01% 5541
2023
Q3
$2.53K Sell
641
-104
-14% -$411 ﹤0.01% 5683
2023
Q2
$2.35K Sell
745
-1
-0.1% -$3 ﹤0.01% 5880
2023
Q1
$1.99K Buy
746
+46
+7% +$123 ﹤0.01% 5900
2022
Q4
$2.51K Buy
700
+1
+0.1% +$4 ﹤0.01% 5631
2022
Q3
$4K Buy
699
+663
+1,842% +$3.79K ﹤0.01% 5668
2022
Q2
$0 Sell
36
-626
-95% ﹤0.01% 7309
2022
Q1
$8K Sell
662
-2,039
-75% -$24.6K ﹤0.01% 6006
2021
Q4
$88K Buy
2,701
+2,686
+17,907% +$87.5K ﹤0.01% 5298
2021
Q3
$1K Hold
15
﹤0.01% 6489
2021
Q2
$1K Sell
15
-881
-98% -$58.7K ﹤0.01% 6424
2021
Q1
$67K Sell
896
-6,725
-88% -$503K ﹤0.01% 5324
2020
Q4
$827K Sell
7,621
-565
-7% -$61.3K ﹤0.01% 4105
2020
Q3
$724K Sell
8,186
-125
-2% -$11.1K ﹤0.01% 3998
2020
Q2
$886K Buy
8,311
+6,034
+265% +$643K ﹤0.01% 3805
2020
Q1
$135K Sell
2,277
-343
-13% -$20.3K ﹤0.01% 4728
2019
Q4
$181K Sell
2,620
-145
-5% -$10K ﹤0.01% 4847
2019
Q3
$287K Sell
2,765
-202
-7% -$21K ﹤0.01% 4595
2019
Q2
$274K Sell
2,967
-239
-7% -$22.1K ﹤0.01% 4626
2019
Q1
$293K Buy
3,206
+721
+29% +$65.9K ﹤0.01% 4571
2018
Q4
$138K Buy
2,485
+1,331
+115% +$73.9K ﹤0.01% 4912
2018
Q3
$137K Sell
1,154
-715
-38% -$84.9K ﹤0.01% 4992
2018
Q2
$191K Buy
1,869
+56
+3% +$5.72K ﹤0.01% 4879
2018
Q1
$235K Buy
1,813
+350
+24% +$45.4K ﹤0.01% 4713
2017
Q4
$143K Sell
1,463
-259
-15% -$25.3K ﹤0.01% 4946
2017
Q3
$253K Buy
1,722
+312
+22% +$45.8K ﹤0.01% 4636
2017
Q2
$227K Hold
1,410
﹤0.01% 4549
2017
Q1
$225K Buy
+1,410
New +$225K ﹤0.01% 4573